key: cord-0770194-mw58pfgr authors: Sanja, Matic; Suzana, Popovic; Predrag, Djurdjevic; Danijela, Todorovic; Natasa, Djordjevic; Zeljko, Mijailovic; Predrag, Sazdanovic; Dragan, Milovanovic; Dejana, Ruzic Zecevic; Marina, Petrovic; Maja, Sazdanovic; Nenad, Zornic; Vladimir, Vukicevic; Ivana, Petrovic; Snezana, Matic; Marina, Karic Vukicevic; Dejan, Baskic title: SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets date: 2020-10-09 journal: bioRxiv DOI: 10.1101/2020.10.09.332858 sha: e5c70d6ceaccaee5a6dbf623a0a5ba1290efb64b doc_id: 770194 cord_uid: mw58pfgr Clinical manifestations of SARS-CoV-2 infection range from mild to critically severe. The aim of the study was to highlight the immunological events associated with the severity of SARS-CoV-2 infection, with an emphasis on cells of innate immunity. Thirty COVID-19 patients with mild/moderate symptoms and 27 patients with severe/critically severe symptoms were recruited from the Clinical Center of Kragujevac during April 2020. Flow cytometric analysis was performed to reveal phenotypic and functional alterations of peripheral blood cells and to correlate them with the severity of the disease. In severe cases, the number of T and B lymphocytes, dendritic cells, NK cells, and HLA-DR-expressing cells was drastically decreased. In the monocyte population proportion between certain subsets was disturbed and cells coexpressing markers of M1 and M2 monocytes were found in intermediate and non-classical subsets. In mild cases decline in lymphocyte number was less pronounced and innate immunity was preserved as indicated by an increased number of myeloid and activated dendritic cells, NK cells that expressed activation marker at the same level as in control and by low expression of M2 marker in monocyte population. In patients with severe disease, both innate and adoptive immunity are devastated, while in patients with mild symptoms decline in lymphocyte number is lesser, and the innate immunity is preserved. lymphocytes, dendritic cells, NK cells, and HLA-DR-expressing cells was drastically decreased. 48 In the monocyte population proportion between certain subsets was disturbed and cells 49 coexpressing markers of M1 and M2 monocytes were found in intermediate and non-classical 50 subsets. In mild cases decline in lymphocyte number was less pronounced and innate immunity 51 was preserved as indicated by an increased number of myeloid and activated dendritic cells, NK 52 cells that expressed activation marker at the same level as in control and by low expression of 53 M2 marker in monocyte population. In patients with severe disease, both innate and adoptive 54 immunity are devastated, while in patients with mild symptoms decline in lymphocyte number is 55 lesser, and the innate immunity is preserved. The median age of patients was 58 years and 35 patients were male (Table 1) biochemical analysis of the whole patient cohort showed that increased granulocytes, glycemia, 165 ALT, LDH, CK, D-dimmer, and CRP were the most typical findings, while oxygen saturation 166 and blood pH were under normal values in the majority of patients (S1 Table) . The values of 167 laboratory parameters were significantly different among MD and SD cases (Table 2) Although in non-severe patients all parameters were close to, or in the normal range, cases, p=0.0032). Of note, all monocytes positive for CD23, co-expressed CD38 as well (Fig 5) . p=0.17; non-classical: 3.6% -control, 17.1% -mild, 48.5% -severe cases, p=0.0021) (Fig 6) . Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a 437 review of immune changes in patients with viral pneumonia COVID-19: Immunology and 440 treatment options Longitudinal hematologic and 442 immunologic variations associated with the progression of COVID-19 patients in China A rapid advice guideline 445 for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia 446 (standard version) Characteristics of lymphocyte subsets and 449 cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus 450 pneumonia (NCP) Dysregulation of immune response in patients with COVID-19 in 453 Lymphocyte Subset Alteration in COVID-19 Pneumonia Functional exhaustion of antiviral 458 lymphocytes in COVID-19 patients Respiratory Syndrome-Associated Coronavirus With Dendritic Cells COVID-19 infection induces readily 464 detectable morphological and inflammation-related phenotypic changes in peripheral blood 465 monocytes, the severity of which correlate with patient outcome Early phases 468 of COVID-19 are characterized by a reduction of lymphocyte populations 3 and the presence 469 of atypical monocytes A consensus Covid-19 472 immune signature combines immuno-protection with discrete sepsis-like traits associated with 473 poor prognosis Organization WH. Clinical management of COVID-19: interim guidance World Health Organization; 2020 Laboratory testing strategy recommendations for COVID-476 19. Interim guidance Restoration of leukomonocyte counts is 479 associated with viral clearance in COVID-19 hospitalized patients Study of the lymphocyte change 482 between COVID-19 and non-COVID-19 pneumonia cases suggesting other factors besides 483 uncontrolled inflammation contributed to multi-organ injury Relationships among lymphocyte subsets, 489 cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected 490 patients Aberrant pathogenic GM-CSF + T cells 492 and inflammatory CD14 + CD16 + monocytes in severe pulmonary syndrome patients of a 493 new coronavirus Antonakos 496 N, et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory 497 A pathological report of three 499 COVID-19 cases by minimal invasive autopsies SARS-CoV-2 invades host cells 502 via a novel route: CD147-spike protein T cell activation-505 associated epitopes of CD147 in regulation of the T cell response, and their definition by 506 antibody affinity and antigen density Dendritic cells prime natural 509 killer cells by trans-presenting interleukin 15 Inhibition of 512 natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of 513 macrophage activation syndrome Coronavirus infections and immune 516 responses Rapid differentiation of 518 monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against 519 influenza virus infection Interaction of severe acute 522 respiratory syndrome-associated coronavirus with dendritic cells Severe acute 525 respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune 526 responses in cultured human monocyte-derived dendritic cells SARS-coronavirus-infected, monocyte-derived human dendritic cells Role of dendritic cells in SARS coronavirus infection Immunoparalysis and adverse outcomes from critical illness Gene expression profiling 536 reveals the defining features of the classical, intermediate, and nonclassical human monocyte 537 subsets The 539 novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients CD14lowCD16high: a cytokine-producing monocyte subset which expands during human 543 immunodeficiency virus infection An unbalanced PD-L1/CD86 ratio in 546 CD14(++)CD16(+) monocytes is correlated with HCV viremia during chronic HCV 547 infection Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human 550 leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue 551 fever A novel 555 multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic 556 sclerosis Pulmonary 559 fibrosis secondary to COVID-19: a call to arms? Haematological and serum biochemistry parameters in COVID-19 patients. The Flow cytometry analysis of T cells in whole blood of COVID-19 patients Smoothed histograms: CD3, CD4 and CD8 expression in patients with severe disease (red), mild 569 disease (blue) and healthy control (green). (D, E) Overlaid contour plot: Identification of 570 Monocyte gating strategy in whole blood. (A) FS vs. SS plot: Wide selection of 573 monocytes depending on FS/SS properties. (B) Pseudocolor CD16 vs. CD14 plot: Gating to 574 select monocytes depending on characteristic Gating to select HLA-DR + cells and to remove NK cells HLA-DR plot: Gating to exclude B cells (HLA-DR high /CD14 low ). (E) Pseudocolor CD16 vs CD14 plot: Gating to select classical (CD14 high CD16 -), intermediates (CD14 high CD16 + ) and non-578 classical (CD14 low CD16 + ) monocytes. (F) Zebra CD16 vs. CD14 plot: Selected monocytes 579 redisplayed on CD16 vs. CD14 zebra plot to visualize monocyte subsets 431 We thank the health workers of the Clinical Centre Kragujevac, doctors and especially 432 technicians, who selflessly, in difficult moments of the struggle for the lives of patients, 433 supported our study. 25 435